Skip to content
Third-party HPLC + mass spec on every lot
Verified: all release criteria met
retired

Certificate of analysis

Survodutide

Lot CP-SURVOD69-2605B · 10 mg

99.82 %

HPLC purity

Spec ≥ 98.0 %

88.5 %

Net peptide content

By amino acid analysis

< 0.31

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory
Colmaric Analyticals
Accreditation
ISO/IEC 17025:2017
Country of synthesis
United States
Manufactured
May 14, 2026
Release tested
May 23, 2026 (4 months ago)
Retest date
May 13, 2028
CAS number
2138731-34-1
Theoretical mass
4737.40 Da
Observed mass (LC-MS)
4737.19 Da (Δ 0.21 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value, not a pass mark alone.

Certificate of analysis: assay results
MethodParameterSpecificationResult
RP-HPLC (UV 214 nm)Purity (area %)≥ 98.0 %99.82 %Pass
LC-MS (ESI+)Identity: observed mass4737.40 ± 1.0 Da4737.19 DaPass
Amino acid analysisNet peptide content≥ 80.0 %88.5 %Pass
Karl FischerWater content≤ 8.0 %3.54 %Pass
Ion chromatographyResidual TFA≤ 1.0 %0.28 %Pass
LAL kinetic chromogenicBacterial endotoxin< 5.0 EU/mg< 0.31 EU/mgPass
USP <71> membrane filtrationSterilityNo growthNo growthPass
Visual / USP <790>AppearanceWhite to off-white cake, free of visible particulatesConformsPass

Handling for this lot

Appearance
White lyophilized cake
Storage
-20 °C lyophilized, protected from light
Reconstitution
If working with sensitive cell lines, note the residual TFA figure on the lot certificate and buffer-exchange if required.

Other lots of Survodutide

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.